Euro-Med Laboratories Phil., Inc. (PSE:EURO)
Philippines flag Philippines · Delayed Price · Currency is PHP
1.370
+0.100 (7.87%)
At close: Nov 17, 2026

PSE:EURO Balance Sheet

Millions PHP. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,4441,206857.62881.35615.72554.5
Trading Asset Securities
312.65312.65233.56202.01190.6173.39
Cash & Short-Term Investments
1,7561,5181,0911,083806.31727.89
Cash Growth
57.23%39.15%0.72%34.36%10.77%-0.62%
Accounts Receivable
2,2181,8411,8071,5921,4391,319
Other Receivables
-113.84132.2111.5243.8744.07
Receivables
2,2181,9551,9401,7031,4831,363
Inventory
1,6441,5821,7421,6931,5371,264
Prepaid Expenses
-317.8330.91321.84317.88296.64
Other Current Assets
367.72249.44214.64334.27283.44259.4
Total Current Assets
5,9875,6235,3185,1354,4283,911
Property, Plant & Equipment
4,7754,8474,9334,9614,9615,052
Long-Term Investments
-0.20.20.20.20.2
Other Intangible Assets
273.58270.13268.13268.13268.13268.21
Long-Term Deferred Tax Assets
119.1115.32122.26109.1597.15105.95
Long-Term Deferred Charges
-12.6512.6521.0738.7951.44
Other Long-Term Assets
299.43276.71295.41268.76266.17302.82
Total Assets
11,45411,14510,95010,76410,0599,691

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
460.53316.7349.49477.38345.59301.14
Accrued Expenses
-113.64139.51104.669.3185.39
Short-Term Debt
3,1792,9983,0403,0142,6332,283
Current Portion of Long-Term Debt
35.03294.91285.65209.75184.3195.08
Current Portion of Leases
22.9656.5566.9858.660.8249.18
Current Income Taxes Payable
41.8850.0226.6151.6431.1822.8
Current Unearned Revenue
-2.120.371.810.750.4
Other Current Liabilities
-0.420.220.110.620.6
Total Current Liabilities
3,7393,8333,9093,9183,3262,937
Long-Term Debt
857.3857.3774.25666.91663.62788.75
Long-Term Leases
159.08105.38125.5389.48138.91105.29
Pension & Post-Retirement Benefits
282.22281.15257.96244.24221.62219.32
Total Liabilities
5,0385,0765,0674,9194,3504,051

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
4,1124,1124,1124,1124,1124,112
Additional Paid-In Capital
66.6166.6166.6166.6166.6166.61
Retained Earnings
2,2541,9061,7241,6921,5471,494
Comprehensive Income & Other
-16.75-16.75-19.77-25.15-16.52-31.79
Shareholders' Equity
6,4166,0685,8835,8455,7095,641
Total Liabilities & Equity
11,45411,14510,95010,76410,0599,691

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
4,2534,3124,2934,0393,6813,421
Net Cash (Debt)
-2,497-2,794-3,202-2,956-2,874-2,693
Net Cash Growth
------
Net Cash Per Share
-0.59-0.68-0.78-0.72-0.70-0.65
Filing Date Shares Outstanding
3,6344,1124,1124,1124,1124,112
Total Common Shares Outstanding
3,6344,1124,1124,1124,1124,112
Working Capital
2,2471,7901,4091,2171,102973.51
Book Value Per Share
1.771.481.431.421.391.37
Tangible Book Value
6,1425,7985,6155,5775,4415,372
Tangible Book Value Per Share
1.691.411.371.361.321.31
Land
-166.77166.77173.34131.83106.59
Buildings
-3,1533,0432,9812,8162,777
Machinery
-6,6576,4996,3656,2786,254